Pages that link to "Q70033743"
Jump to navigation
Jump to search
The following pages link to No D2 receptor increase in PET study of schizophrenia (Q70033743):
Displaying 50 items.
- 3H-Spiperone labels sigma receptors, not dopamine D2 receptors, in rat and human lymphocytes (Q23922388) (← links)
- Dopaminergic dysfunction in schizophrenia: salience attribution revisited. (Q30475711) (← links)
- Positron emission tomography and magnetic resonance imaging: A review and a local circuit neurons hypo(dys)function hypothesis of schizophrenia (Q31111338) (← links)
- Deconstructing psychosis with human brain imaging (Q31114592) (← links)
- Structural and functional brain imaging in schizophrenia (Q33396727) (← links)
- Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes (Q33729433) (← links)
- Measurement of density and affinity for dopamine D(2) receptors by a single positron emission tomography scan with multiple injections of [(11)C]raclopride. (Q34170886) (← links)
- Localization of the mRNA for the dopamine D2 receptor in the rat brain by in situ hybridization histochemistry (Q34317483) (← links)
- Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management (Q34558583) (← links)
- Dopaminergic dysfunction in alcoholism and schizophrenia--psychopathological and behavioral correlates (Q34579920) (← links)
- Neuropsychiatric disorders: investigation of schizophrenia and substance abuse (Q35532407) (← links)
- Uses and Limitations of Positron Emission Tomography in Clinical Pharmacokinetics/Dynamics (Part II) (Q36215997) (← links)
- Positron emission tomography studies of brain receptors (Q36503237) (← links)
- D1and D2and D3 (Q36534005) (← links)
- PET imaging of dopamine receptors in human basal ganglia: relevance to mental illness (Q36586088) (← links)
- Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task (Q36636329) (← links)
- The dopamine system and the pathophysiology of schizophrenia: a basic science perspective (Q36756361) (← links)
- Dopamine genes and schizophrenia: case closed or evidence pending? (Q36881176) (← links)
- Studies of central nervous system disorders with single photon emission computed tomography and positron emission tomography: evolution over the past 2 decades (Q37645218) (← links)
- PET scanning (Q38223456) (← links)
- Endocrine aspects of postnatal mental disorders (Q38784241) (← links)
- The ageing brain, neuroleptic drugs and the enigma of schizophrenia (Q39472243) (← links)
- New approaches to the drug treatment of schizophrenia (Q40524584) (← links)
- Neurotransmitter systems in schizophrenia. (Q40932666) (← links)
- The importance of dopamine D4 receptors in the action and development of antipsychotic agents (Q41064350) (← links)
- Clinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia (Q41133694) (← links)
- D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics (Q41277818) (← links)
- Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels (Q41278279) (← links)
- Schizophrenia and antipsychotic somatic treatment (Q41459295) (← links)
- The neuroanatomy and neurochemistry of schizophrenia (Q41743479) (← links)
- Case reports of the reemergence of psychotic symptoms after conversion from brand-name clozapine to a generic formulation (Q43810735) (← links)
- Effects of endogenous dopamine on measures of [18F]N-methylspiroperidol binding in the basal ganglia: Comparison of simulations and experimental results from PET studies in baboons (Q44642302) (← links)
- Effects of endogenous dopamine on kinetics of [3H]N-methylspiperone and [3H]raclopride binding in the rat brain (Q45068213) (← links)
- Parsing Schizophrenia with Neurocognitive Tests: Evidence of Stability and Validity (Q46031535) (← links)
- The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychotics (Q46051346) (← links)
- Sequential versus nonsequential measurement of density and affinity of dopamine D2 receptors with [11C]raclopride: 2: effects of DAT inhibitors (Q46562388) (← links)
- The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia (Q46764266) (← links)
- Stereoselective binding of 11C-raclopride in living human brain--a search for extrastriatal central D2-dopamine receptors by PET. (Q48152915) (← links)
- Effects of dopamine on the in vivo binding of dopamine D2 receptor radioligands in rat striatum (Q48252711) (← links)
- Functional polymorphism of -141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia (Q48326374) (← links)
- N-[11C]methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic (Q48386184) (← links)
- Dopamine D2 densities and the schizophrenic brain. (Q48404440) (← links)
- Serum amino acid profiles and dopamine in schizophrenic patients and healthy subjects: Window to the brain? (Q48530740) (← links)
- The Binding of Both [3H]Nemonapride and [3H]Raclopride Is Increased in Schizophrenia (Q48610567) (← links)
- In vivo binding of spiperone and N-methylspiperone to dopaminergic and serotonergic sites in the rat brain: multiple modeling and implications for PET scanning (Q49015036) (← links)
- The neuropsychology of schizophrenia: A perspective from neurobehavioral genetics (Q56896418) (← links)
- Why don't preschizophrenic children have delusions and hallucinations? (Q57403541) (← links)
- (3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients (Q57781184) (← links)
- 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms (Q57781187) (← links)
- The D4 and schizophrenia (Q60066229) (← links)